5 Results for "

senescence-associated β-galactosidase

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "senescence-associated β-galactosidase" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-N8211
CAS No.: 94987-09-4
Gypenoside L is a saponin that can be found in Gynostemma pentaphyllum. Gypenoside L increases the SA-β-galactosidase activity, promotes the production of senescence-associated secretory cytokines. Gypenoside L also can activate p38 and ERK MAPK pathways and NF-κB pathway to induce senescence. Gypenoside L exhibits anti-tumor and anti-inflammatory activities .
loading...
    loading...
Cat. No.: HY-165424
CAS No.: 3036456-18-2
NIR-BG2 is a fluorescent indicator targeting senescence-associated β-galactosidase (SA-β-Gal). NIR-BG2 contains a hemicyanine fluorophore caged by SA-β-Gal; cleavage of its β-galactosyl group by SA-β-Gal generates an electrophilic quinone methide, which can form covalent bonds with adjacent proteins to achieve long-term signal retention. NIR-BG2 activates a near-infrared fluorescent signal upon recognition of SA-β-Gal. NIR-BG2 can be used for non-invasive in vivo imaging of cellular senescence in mouse xenograft models. The excitation/emission wavelengths are 675/708 nm .
loading...
    loading...
Cat. No.: HY-182898
CAS No.: 3051812-84-8
Target:  

Apoptosis Glycosidase

Research Areas:  

Inflammation/Immunology

Gal-dMor-Gem is a selective senescent cell scavenger, Apoptosis inducer, and a prodrug of Gemcitabine (HY-17026). Gal-dMor-Gem releases Gemcitabine upon activation by Esterases and β-gal. Gal-dMor-Gem reduces SA-β-gal, preferentially induces apoptosis in senescent cells, regulates apoptosis-related proteins, accumulates in senescent tissues, and ameliorates senescence-related organ phenotypes. Gal-dMor-Gem is applicable to research on chemotherapy-induced senescence .
loading...
    loading...
Cat. No.: HY-188142
CAS No.: 259684-23-6
Target:  

Drug Intermediate

Research Areas:  

Cancer

Gal-PAB is a galactose-linker conjugate that can be used for the synthesis of the galactose-modified PROTAC prodrug Gal-ARV-771 (HY-158331). Gal-PAB is applicable to lung cancer research .
loading...
    loading...
Cat. No.: HY-187365
Target:  

Glycosidase

Research Areas:  

Inflammation/Immunology

UCM-17017 is a tetrasubstituted cyclohexene inhibitor that inhibits the activity of senescent cell SA-β-gal with an IC50 of 0.4 μM. UCM-17017 selectively reduces the viability of senescent cancer cells, and this effect is stronger than its impact on proliferating cells. UCM-17017 binds to human serum albumin with a KD of 230 μM. UCM-17017 reduces collagen deposition and decreases the expression of the inflammatory marker Ccl2 in a mouse model of pulmonary fibrosis. UCM-17017 can be used in studies related to senescence and pulmonary fibrosis .
loading...
    loading...